{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T10:55:08Z","timestamp":1787136908454,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T00:00:00Z","timestamp":1649980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.numecd.2022.03.031","type":"journal-article","created":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T11:20:38Z","timestamp":1649848838000},"page":"1719-1724","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Minimed Medtronic 780G optimizes glucose control in patients with type 1 diabetes mellitus"],"prefix":"10.1016","volume":"32","author":[{"given":"Basilio","family":"Pintaudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Gironi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Nicosia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Meneghini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Disoteo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Mion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9994-8472","authenticated-orcid":false,"given":"Federico","family":"Bertuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2022.03.031_bib1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1089\/dia.2019.0417","article-title":"The efficacy of technology in type 1 diabetes: a systematic review, network meta-analysis, and narrative synthesis","volume":"22","author":"Pease","year":"2020","journal-title":"Diabetes Technol Therapeut"},{"issue":"Supp 1","key":"10.1016\/j.numecd.2022.03.031_bib2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/dom.14576","article-title":"The automated pancreas: a review of technologies and clinical practice","volume":"24","author":"Biester","year":"2022","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.numecd.2022.03.031_bib3","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/dom.14273","article-title":"Hybrid closed-loop therapy: where are we in 2021?","volume":"23","author":"Leelarathna","year":"2021","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.numecd.2022.03.031_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/dia.2016.0421","article-title":"Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes","volume":"19","author":"Garg","year":"2017","journal-title":"Diabetes Technol Therapeut"},{"key":"10.1016\/j.numecd.2022.03.031_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020274","article-title":"Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocol","volume":"8","author":"McAuley","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.numecd.2022.03.031_bib6","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.2337\/dc20-1447","article-title":"Six months of hybrid closed-loop versus manual insulin delivery with fingerprick blood glucose monitoring in adults with type 1 diabetes: a randomized, controlled trial","volume":"43","author":"McAuley","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2022.03.031_bib7","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1089\/dia.2021.0176","article-title":"Real-world, patient-reported and clinic data from individuals with type 1 diabetes using the MiniMed 670G hybrid closed-loop system","volume":"23","author":"DuBose","year":"2021","journal-title":"Diabetes Technol Therapeut"},{"key":"10.1016\/j.numecd.2022.03.031_bib8","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1111\/dom.14424","article-title":"Real-world performance of the MiniMed 670G system in europe","volume":"23","author":"Da Silva","year":"2021","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.numecd.2022.03.031_bib9","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/dom.14355","article-title":"Hybrid closed-loop glucose control with faster insulin aspart compared with standard insulin aspart in adults with type 1 diabetes: a double-blind, multicentre, multinational, randomized, crossover study","volume":"23","author":"Boughton","year":"2021","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.numecd.2022.03.031_bib10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1089\/dia.2018.0328","article-title":"Cost-effectiveness analysis of the MiniMed 670G hybrid closed-loop system versus continuous subcutaneous insulin infusion for treatment of type 1 diabetes","volume":"21","author":"Jendle","year":"2019","journal-title":"Diabetes Technol Therapeut"},{"key":"10.1016\/j.numecd.2022.03.031_bib11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/dia.2019.0011","article-title":"Successful at-home use of the Tandem Control-IQ artificial pancreas system in young children during a randomized controlled trial","volume":"21","author":"Forlenza","year":"2019","journal-title":"Diabetes Technol Therapeut"},{"key":"10.1016\/j.numecd.2022.03.031_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1089\/dia.2021.0203","article-title":"Real-world performance of the MiniMed 780G system: first report of outcomes from 4'120 users","volume":"24","author":"Da Silva","year":"2022","journal-title":"Diabetes Technol Therapeut"},{"key":"10.1016\/j.numecd.2022.03.031_bib13","doi-asserted-by":"crossref","first-page":"108986","DOI":"10.1016\/j.diabres.2021.108986","article-title":"Amelioration of user experiences and glycaemic outcomes with an Advanced Hybrid Closed Loop System in a real-world clinical setting","volume":"178","author":"Beato-V\u00edbora","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.numecd.2022.03.031_bib14","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2337\/dc20-2250","article-title":"Improved glycemic outcomes with Medtronic MiniMed advanced hybrid closed-loop delivery: results from a randomized crossover trial comparing automated insulin delivery with predictive low glucose suspend in people with type 1 diabetes","volume":"44","author":"Collyns","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2022.03.031_bib16","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1177\/1932296816645119","article-title":"Home closed loop study group. Efficacy of an overnight predictive low-glucose suspend system in relation to hypoglycemia risk factors in youth and adults with type 1 diabetes","volume":"10","author":"Calhoun","year":"2016","journal-title":"J Diabetes Sci Technol"},{"issue":"Suppl 2","key":"10.1016\/j.numecd.2022.03.031_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/dom.12142","article-title":"How can we monitor glycaemic variability in the clinical setting?","volume":"15","author":"Inchiostro","year":"2013","journal-title":"Diabetes Obes Metabol"},{"issue":"4","key":"10.1016\/j.numecd.2022.03.031_bib18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.diabet.2018.02.008","article-title":"The application of simple metrics in the assessment of glycaemic variability","volume":"44","author":"Monnier","year":"2018","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.numecd.2022.03.031_bib19","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1177\/0963689718763751","article-title":"Long-term effect of islet transplantation on glycemic variability","volume":"27","author":"Bertuzzi","year":"2018","journal-title":"Cell Transplant"},{"key":"10.1016\/j.numecd.2022.03.031_bib20","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1007\/s00125-021-05568-3","article-title":"The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"64","author":"Holt","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2022.03.031_bib21","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2337\/dc17-1600","article-title":"International consensus on use of continuous glucose monitoring","volume":"40","author":"Danne","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2022.03.031_bib22","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2022.03.031_bib23","doi-asserted-by":"crossref","first-page":"802419","DOI":"10.3389\/fendo.2021.802419","article-title":"A comparison of two hybrid closed-loop systems in Italian children and adults with type 1 diabetes","volume":"12","author":"Bassi","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.numecd.2022.03.031_bib24","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1089\/dia.2019.0400","article-title":"Prospective analysis of the impact of commercialized hybrid closed-loop system on glycemic control, glycemic variability, and patient-related outcomes in children and adults: a focus on superiority over predictive low-glucose suspend technology","volume":"22","author":"Beato-V\u00edbora","year":"2020","journal-title":"Diabetes Technol Therapeut"},{"key":"10.1016\/j.numecd.2022.03.031_bib25","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1089\/dia.2020.0388","article-title":"Real-world patient-reported outcomes and glycemic results with initiation of Control-IQ Technology","volume":"23","author":"Pinsker","year":"2021","journal-title":"Diabetes Technol Therapeut"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475322001673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475322001673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:21:04Z","timestamp":1760545264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475322001673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0939475322001673"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2022.03.031","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Minimed Medtronic 780G optimizes glucose control in patients with type 1 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2022.03.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V. on behalf of The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University.","name":"copyright","label":"Copyright"}]}}